Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures

European Journal of Clinical Pharmacology

Volumn 62, Issue 4, 2006, Pages 325-329

  Dmoszynska, Anna ^a   Podhorecka, Monika ^a   Klimek, Piotr ^a   Grzasko, Norbert ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Apoptosis; Lovastatin; Multiple myeloma; Thalidomide

Indexed keywords

LIPOCORTIN 5; MEVINOLIN; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2; SYNDECAN 1; THALIDOMIDE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CELL POPULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; KINETICS; LOVASTATIN; MULTIPLE MYELOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; THALIDOMIDE; TUMOR CELLS, CULTURED;

EID: 33645664011     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0106-2     Document Type: Article

References (17)

1. Agarwal B, Bhendwal S, Halmos B, Moss SF, Ramey WG, Holt PR (1999) Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res 5:2223-2229
2. Calabrese L, Fleischer AB (2000) Thalidomide: current and potential clinical applications. Am J Med 108:487-495
3. Dmoszynska A, Rolinski J, Bojarska-Junak A, Manko J, Jawniak D, Walter-Croneck A, Soroka-Wojtaszko M (2001) Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients. Pol J Pharmacol 53:709-713
4. Dmoszyńska A, Podhorecka M, Roliński J, Soroka-Wojtaszko M (2004) Influence of lovastatin on BCL-2 and BAX expression by plasma cells and T lymphocytes in short-term cultures of multiple myeloma bone marrow mononuclear cells. Pol J Pharmacol 56:485-489
5. Feleszko W, Młynarczyk J, Balkiewiec-Iskra EZ, Cajak A, Switaj T, Stokłosa T, Giermasz A, Jakobisiak M (2000) Lovastatin potentiates antitumor activity and atenuates cardiotoxicity of doxorubicin in three tumor models in mice. Clin Cancer Res 6:2044-2052
6. Kneller A, Raanani P, Hardan I, Avigdor A, Levi I, Berkowicz M, Ben-Bassat I (2000) Therapy with thalidomide in refractory multiple myeloma patients: the revival of an old drug. Br J Haematol 108:391-393
7. Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J (1995) Interleukion 6 inhibits apoptosis of malignant plasma cells. Cell Immunol 162:248-255
8. Lishner M, Bar-Sef A, Elis A, Fabian I (2001) Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines. J Investig Med 49:319-324
9. Marriot JB, Muller G, Dalgleish AG (1999) Thalidomide as an emerging immunotherapeutic agent. Immunol Today 20:538-554
10. Moncada B, Baranda ML, Gonzales-Amaro R, Urbina R, Loredo CE (1985) Thalidomide - effect on T cell subsets is a possible mechanisms of action. Int J Lepr Other Mycobact Dis 53:201-205
11. Reed JC (1998) BCL-2 family proteins. Oncogene 17:3225-3236
12. Sampaio EP, Sarno NN, Galilly R, Cohn ZA, Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor α production by stimulated human monocytes. J Exp Med 173:699-703
13. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (1999) Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565-1571
14. Spets H, Stromberg T, Georgii Hemminng P, Siljason J, Nilsson K, Jernberg-Wiklund H (2002) Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells : regulation during interleukin-6 -induced growth and survival. Eur J Haematol 69:76-89
15. Thibault A, Samid D, Tompkims AC (1996) Phase I study of lovastatin an inhibitor of the mevalonate pathway in patients with cancer. Clin Cancer Res 2:483-491
16. Van de Donk NW, Kamphuis MM, Lokhorst HM, Bloem AC (2002) The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells. Leukemia 16:1362-1371
17. Weis M, Heeschen C, Glassford AJ, Cooke JP (2002) Statins have biphasic effects on angiogenesis. Circulation 105:739-748